ID   RTSG
AC   CVCL_1671
DR   ArrayExpress; E-MTAB-783
DR   BioSample; SAMN03151924
DR   BioSample; SAMN03472783
DR   CGH-DB; 9361-4
DR   Cosmic; 909705
DR   IARC_TP53; 21294
DR   JCRB; IFO50318
DR   Wikidata; Q54951452
RX   PubMed=2083225;
RX   PubMed=11330945;
RX   PubMed=20164919;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; Promega; -; http://promega.co.jp/pdf/Cell_Authentication.pdf
CC   Problematic cell line: Contaminated. Shown to be a SNG-II derivative (JCRB=IFO50318). Originally thougth to originate from the pleural effusion of a 66 year old female patient with metastatic ovarian epithelial carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00423.
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=2083225).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: JCRB; IFO50318; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): JCRB=IFO50318
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,9,12
ST   D16S539: 12,13,14
ST   D5S818: 6,12
ST   D7S820: 9,11,12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 15,16,17
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3170 ! SNG-II
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
RX   PubMed=20164919; DOI=10.1038/nature08768; PMCID=PMC3145113;
RA   Bignell, Graham Robert
RA   Greenman, Christopher D.
RA   Davies, Helen R.
RA   Butler, Adam P.
RA   Edkins, Sarah
RA   Andrews, Jenny M.
RA   Buck, Gemma
RA   Chen, Lina
RA   Beare, David
RA   Latimer, Calli
RA   Widaa, Sara
RA   Hinton, Jonathan
RA   Fahey, Ciara
RA   Fu, Bei-Yuan
RA   Swamy, Sajani
RA   Dalgliesh, Gillian L.
RA   Teh, Bin Tean
RA   Deloukas, Panos
RA   Yang, Feng-Tang
RA   Campbell, Peter J.
RA   Futreal, P. Andrew
RA   Stratton, Michael Rudolf
RT   "Signatures of mutation and selection in the cancer genome.";
RL   Nature 463:893-898(2010).
//
RX   PubMed=2083225;
RA   Udagawa, Yasuhiro
RA   Nozawa, Shiro
RA   Chin, Keiko
RA   Sakayori, Motoko
RA   Mikami, Mikio
RA   Ohta, Kunihiko
RA   Tsukazaki, Katsumi
RA   Kiguchi, Kazushige
RA   Iizuka, Rihachi
RT   "Establishment and characterization of a human chorionic gonadotropin
RT   (hCG) producing cell line (RTSG) from an ovarian epithelial cancer.";
RL   Hum. Cell 3:70-75(1990).
//
RX   PubMed=11330945; DOI=10.1006/gyno.2001.6132;
RA   Watanabe, Takafumi
RA   Imoto, Issei
RA   Kosugi, Yoshinori
RA   Ishiwata, Isamu
RA   Inoue, Satoshi
RA   Takayama, Masaomi
RA   Sato, Akira
RA   Inazawa, Johji
RT   "A novel amplification at 17q21-23 in ovarian cancer cell lines
RT   detected by comparative genomic hybridization.";
RL   Gynecol. Oncol. 81:172-177(2001).
//